Enzon Pharmaceuticals Inc
(ENZN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 31,173 | 34,493 | 42,600 | 48,072 | 97,865 |
| Gross Profit | 31,173 | 34,493 | 42,600 | 48,072 | 97,865 |
| Operating Expenses | 2,383 | 16,334 | 46,566 | 64,527 | 98,440 |
| Operating Income | 28,790 | 18,159 | -3,966 | -16,455 | -575 |
| Interest Expense | 0 | 2,124 | 5,330 | 5,929 | 6,315 |
| Other Income | 61 | 2,087 | 2,378 | 1,826 | 3,753 |
| Pre-tax Income | 28,851 | 18,122 | -6,918 | -20,558 | -3,137 |
| Income Tax | 56 | -28 | -4,135 | 205 | -337 |
| Net Income Continuous | 28,795 | 18,150 | -2,783 | -20,763 | -2,800 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 180,043 |
| Net Income | $28,795 | $18,150 | $-2,783 | $-20,763 | $177,243 |
| EPS Basic Total Ops | 0.65 | 0.41 | -0.06 | -0.40 | 3.03 |
| EPS Basic Continuous Ops | 0.65 | 0.41 | -0.06 | -0.40 | -0.05 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 3.08 |
| EPS Diluted Total Ops | 0.65 | 0.38 | -0.06 | -0.40 | 3.03 |
| EPS Diluted Continuous Ops | 0.65 | 0.36 | -0.06 | -0.40 | -0.05 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 3.08 |
| EBITDA(a) | $28,790 | $19,319 | $3,880 | $-9,013 | $8,402 |